Pennant Group Inc. (PNTG)
NASDAQ: PNTG
· Real-Time Price · USD
29.36
0.05 (0.17%)
At close: May 15, 2025, 3:26 PM
Pennant Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Home Health And Hospice Services Segment Revenue | 515.34M | 394.46M | 342.25M | 309.57M | 253.66M | 206.62M |
| Home Health And Hospice Services Segment Revenue Growth | +30.64% | +15.26% | +10.56% | +22.04% | +22.76% | n/a |
| Senior Living Services Segment Revenue | 175.76M | 150.43M | 130.99M | 130.12M | 137.29M | 131.91M |
| Senior Living Services Segment Revenue Growth | +16.84% | +14.84% | +0.67% | -5.22% | +4.08% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 13.87M | 13.02M | 11.48M | 11.93M | 10.05M | 9.42M | 8.79M | 8.71M | 8.33M | 5.88M | 9.74M | 10.03M | 9.12M | 9.07M | 8.78M | 9.29M | 9.6M | 7.5M | 7.54M | 6.66M | 11.43M | 8.58M | 6.89M | 8.24M | 5.39M | 4.46M | 11.66M | 12.62M |
| Selling, General, and Administrative Revenue Growth | +6.52% | +13.44% | -3.75% | +18.70% | +6.70% | +7.12% | +0.99% | +4.53% | +41.66% | -39.65% | -2.91% | +9.99% | +0.62% | +3.22% | -5.44% | -3.22% | +27.96% | -0.50% | +13.17% | -41.70% | +33.21% | +24.50% | -16.44% | +53.04% | +20.65% | -61.70% | -7.65% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |